Azernews.Az

Bloomberg

European stock-index futures rose, indicating equities will extend a two-month high, before a survey on German business confidence. U.S. stock-index futures were little changed, while Asian shares climbed.

Contracts on the Euro Stoxx 50 Index expiring in December advanced 0.5 percent to 3,205 at 7:15 a.m. in London. The Stoxx Europe 600 Index gained 2.9 percent last week as Mario Draghi said the European Central Bank needs to accelerate inflation and may broaden its asset-purchase program, while China cut benchmark interest rates for the first time since 2012.

Standard & Poor’s 500 Index futures expiring in December added 0.1 percent today, while the MSCI Asia Pacific Index advanced 0.7 percent.

The Stoxx 600 rallied 11.4 percent from its low in October through the end of last week, sending its valuation to the highest level since December 2009. The gauge trades at 15.8 times estimated profit, data compiled by Bloomberg show.

In a bid to jumpstart private risk-taking, the European Union will announce the creation of a 21 billion-euro ($26 billion) fund, two EU officials said. European Commission President Jean-Claude Juncker is due to announce the three-year initiative this week.

The entity will share the risk of new projects with private investors, and the commission will pledge as much as 16 billion euros in guarantees for the vehicle, which will also include 5 billion euros from the European Investment Bank.

German business confidence probably fell for a seventh month in November, data may show at 10 a.m. Frankfurt time. The Ifo institute’s business climate index, based on a survey of 7,000 executives, slid to 103 from 103.2 in the previous month, according to the median economist forecast.

BHP Billiton Ltd. may be active as the world’s biggest miner reassured investors that planned capital spending and cost cuts will help allow it to maintain dividends. Syngenta AG may move after saying it will cut jobs as it targets savings of $1 billion by 2018. Novartis AG may be active after one of its treatments obtained European Union approval.